Literature DB >> 2984099

Ovine corticotropin-releasing factor administration in normal men. Pituitary and adrenal responses in the morning and evening.

H M Schulte, G P Chrousos, E H Oldfield, P W Gold, G B Cutler, D L Loriaux.   

Abstract

We administered ovine corticotropin-releasing factor (CRF) as a bolus intravenous injection (1 microgram/kg) at 09.00 and at 20.00 to assess the influence of circadian changes in the hypothalamic-pituitary-adrenal axis on the response to CRF. The increase in plasma ACTH levels after CRF was only slightly lower in the morning than in the evening. The plasma cortisol response to ACTH, however, was significantly greater in the evening than in the morning (p less than 0.005). At both times of day CRF administration had no effect on plasma concentrations of GH, PRL, LH, AVP, insulin, PRA or glucose. No effects were observed on the hematopoietic system, kidneys or liver. In addition, CRF had no effect on heart rate, blood pressure or respiratory rate at the dose employed. Approximately 10% of the subjects complained of a transient upper body and facial hot flush. These observations indicate that the magnitude of the plasma cortisol rise after CRF depends on the time of administration.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2984099     DOI: 10.1159/000180028

Source DB:  PubMed          Journal:  Horm Res        ISSN: 0301-0163


  7 in total

Review 1.  Safety and side effects of human and ovine corticotropin-releasing hormone administration in man.

Authors:  M Nink; U Krause; H Lehnert; J Beyer
Journal:  Klin Wochenschr       Date:  1991-03-18

2.  Continuous administration of synthetic ovine corticotropin-releasing factor in man. Physiological and pathophysiological implications.

Authors:  H M Schulte; G P Chrousos; P W Gold; J D Booth; E H Oldfield; G B Cutler; D L Loriaux
Journal:  J Clin Invest       Date:  1985-06       Impact factor: 14.808

3.  Cushing disease: successful preoperative lateralization of an ACTH-producing pituitary microadenoma by simultaneous bilateral inferior petrosal venous sinus sampling with corticotropin-releasing hormone stimulation.

Authors:  B P Hauffa; H Stolecke; H M Schulte
Journal:  Eur J Pediatr       Date:  1986-12       Impact factor: 3.183

4.  Hereditary isolated glucocorticoid deficiency is associated with abnormalities of the adrenocorticotropin receptor gene.

Authors:  C Tsigos; K Arai; W Hung; G P Chrousos
Journal:  J Clin Invest       Date:  1993-11       Impact factor: 14.808

5.  Corticotropin-releasing factor and adrenal function in major depression.

Authors:  D Nerozzi; G Bersani; E Melia; A Magnani; I Antonozzi; G Frajese
Journal:  J Endocrinol Invest       Date:  1988-11       Impact factor: 4.256

6.  Stimulation by hCRF of C-peptide release in type 2 diabetics during concomitant opioid receptor blockade.

Authors:  H Ehrenreich; C Kolmar; C Pittius; F D Goebel
Journal:  Klin Wochenschr       Date:  1988-02-15

7.  Vasopressin stimulation of adrenocorticotropin hormone (ACTH) in humans. In vivo bioassay of corticotropin-releasing factor (CRF) which provides evidence for CRF mediation of the diurnal rhythm of ACTH.

Authors:  R A Salata; D B Jarrett; J G Verbalis; A G Robinson
Journal:  J Clin Invest       Date:  1988-03       Impact factor: 14.808

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.